ClinicalTrials.govpublic full text
Effects of Cyproterone Compound-spironolactone, Metformin and Pioglitazone on Inflammatory Markers in PCOS
polycystic ovary syndrome
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 303701
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.